Abstract
To examine antimicrobial management of brain abscess and prioritize future trials. Self-administered, Internet-based survey of practices for treatment of community-acquired bacterial brain abscess among infectious diseases (ID) specialists in France, Sweden, Australia, and Denmark during November 2019. Respondents were also asked to rank future randomized controlled trials (RCTs) from 1 (high priority) to 6 (low priority). 310 ID specialists (45% female) from France (35%), Sweden (29%), Australia (25%), and Denmark (11%) participated in the survey, primarily from university hospitals (69%) with an on-site neurosurgical department (61%). Preferred empiric intravenous (IV) antimicrobials were cefotaxime (154/273, 56%) or ceftriaxone (68/273, 25%) combined with metronidazole for a median of 4 weeks (IQR 4–6), 4 weeks (IQR 2–4), and 6 weeks (IQR 4–6) for aspirated, excised, and conservatively treated patients, respectively. Early transition to oral antimicrobials (i.e., < 4 weeks of IV antimicrobials) was used by 134/269 (50%), whereas consolidation therapy with oral antimicrobials after a standard IV regimen (i.e., 4–8 weeks) was used by 123/264 (47%). Median prioritization scores for future RCTs were as follows: 1 (IQR 1–2) for an early transition to oral antimicrobials and duration of therapy, 3 (IQR 2–4) for comparisons of antimicrobial regimens, use of adjunctive dexamethasone, and neurosurgical aspiration versus excision, and 4 (IQR 3–5) for intracavitary antimicrobial instillation and drainage, and for prophylactic anti-epileptic therapy. Willingness to include patients into RCTs reflected prioritization scores. Duration of intravenous antimicrobial treatment and use of oral antimicrobials varies substantially among ID specialists. RCTs are needed to define optimal treatment of brain abscess.
Similar content being viewed by others
References
Bodilsen J, Dalager-Pedersen M, van de Beek D, Brouwer MC, Nielsen H (2019) Incidence and mortality of brain abscess in Denmark: a nationwide population-based study. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2019.05.016
Bodilsen J, Dalager-Pedersen M, van de Beek D, Brouwer MC, Nielsen H (2019) Long-term mortality and epilepsy in patients after brain abscess: a nationwide population-based matched cohort study. Clin Infect Dis. https://doi.org/10.1093/cid/ciz1153
Bodilsen J, Brouwer MC, Nielsen H, van de Beek D (2018) Anti-infective treatment of brain abscess. Expert Rev Anti-Infect Ther 16:565–578. https://doi.org/10.1080/14787210.2018.1489722
Brouwer MC, Tunkel AR, Guy MM, van de Beek D (2014) Brain abscess. N Engl J Med 371:447–456. https://doi.org/10.1056/nejmra1301635
Muzumdar D, Jhawar S, Goel A (2011) Brain abscess: an overview. Int J Surg 9:136–144. https://doi.org/10.1016/j.ijsu.2010.11.005
Sonneville R, Ruimy R, Benzonana N, Riffaud L, Carsin A, Tadié J et al (2017) An update on bacterial brain abscess in immunocompetent patients. Clin Microbiol Infect 23:614–620. https://doi.org/10.1016/j.cmi.2017.05.004
Scheld MW, Whitley RJ, Marra CM (2014) Infections of the central nervous system, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Bennett JE, Dolin R, Blaser MJ (2020) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 9th edn. Elsevier Health Sciences, Philadelphia
Mathisen G, Johnson J (1997) Brain abscess. Clin Infect Dis 25:763–779 quiz 780–1
Louvois R (2000) The rational use of antibiotics in the treatment of brain abscess. Br J Neurosurg 14:525–530. https://doi.org/10.1080/02688690020005527
Jansson A, Enblad P, Sjölin J (2004) Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 23:7–14. https://doi.org/10.1007/s10096-003-1055-7
Jamjoom A (1996) Short course antimicrobial therapy in intracranial abscess. Acta Neurochir 138:835–839
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Bodilsen J, Storgaard M, Larsen L, Wiese L, Helweg-Larsen J, Lebech A-M et al (2018) Infectious meningitis and encephalitis in adults in Denmark: a prospective nationwide observational cohort study (DASGIB). Clin Microbiol Infect 24:1102.e1–1102.e5. https://doi.org/10.1016/j.cmi.2018.01.016
Réseau National de Recherche Clinique en Infectiologie (RENARCI). Available at: https://www.infectiologie.com/fr/renarci.html. Accessed January 20, 2020.
Watson D (2003) Ozbug: an email mailing list for physicians that works. Intern Med J 33:532–534. https://doi.org/10.1046/j.1445-5994.2003.00450.x
Blâckberg J, Brink M, Ericsson M, Glimåker M, Johansson B, Lindquist L et al Vårdprogram for Bakterialla CNS-infektioner (Swedish). Available at: https://infektion.net/wp-content/uploads/2017/05/vardpr_cns_100916.pdf. Accessed on February 12, 2020.
Antibiotic Expert Group (2018) Therapeutic guidelines: antibiotic. Version 16. Therapeutic Guidelines Ltd, Melbourne
Sjolin J, Lilja A, Eriksson N, Arneborn P, Cars O (1993) Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis 17:857–863. https://doi.org/10.1093/clinids/17.5.857
Sjolin J, Eriksson N, Arneborn P, Cars O (1991) Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrob Agents Chemother 35:2606–2610. https://doi.org/10.1128/aac.35.12.2606
Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT et al (2019) Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med 380:415–424. https://doi.org/10.1056/nejmoa1808312
Li H-K, Rombach I, Zambellas R, Walker SA, McNally MA, Atkins BL et al (2019) Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med 380:425–436. https://doi.org/10.1056/nejmoa1710926
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R et al (2018) Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis 52:1232–1238. https://doi.org/10.1093/cid/ciy1054
Uranga A, España PP, Bilbao A, Quintana J, Arriaga I, Intxausti M et al (2016) Duration of antibiotic treatment in community-acquired pneumonia. JAMA Intern Med 176:1257–1259. https://doi.org/10.1001/jamainternmed.2016.3633
Molyneux E, Nizami S, Saha S, Huu K, Azam M, Bhutta Z et al (2011) 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study. Lancet 377:1837–1845. https://doi.org/10.1016/s0140-6736(11)60580-1
Skoutelis A, Gogos C, Maraziotis T, Bassaris H (2000) Management of brain abscesses with sequential intravenous/oral antibiotic therapy. Eur J Clin Microbiol Infect Dis 19:332–335
Xia C, Jiang X, Niu C (2016) May short-course intravenous antimicrobial administration be as a standard therapy for bacterial brain abscess treated surgically? Neurol Res 38:413–419. https://doi.org/10.1080/01616412.2016.1177928
Carpenter J, Stapleton S, Holliman R (2006) Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 26:1–11. https://doi.org/10.1007/s10096-006-0236-6
Sichizya K, Fieggen G, Taylor A, Peter J (2005) Brain abscesses--the Groote Schuur experience, 1993-2003. S Afr J Surg 43:79–82
Author information
Authors and Affiliations
Contributions
All authors contributed in design, analysis, and interpretation of data. JB wrote the first draft of the report.
Corresponding author
Ethics declarations
Approval from an ethical committee was not required for this type of study in the participating countries.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This study is a collaborative study within the European Study Group for Infectious diseases of the Brain (ESGIB).
Electronic supplementary material
ESM 1
(DOCX 121 kb).
Rights and permissions
About this article
Cite this article
Bodilsen, J., Tattevin, P., Tong, S. et al. Treatment of community-acquired bacterial brain abscess: a survey among infectious diseases specialists in France, Sweden, Australia, and Denmark. Eur J Clin Microbiol Infect Dis 40, 255–260 (2021). https://doi.org/10.1007/s10096-020-04032-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-020-04032-1